首页> 外文期刊>AIDS Research and Human Retroviruses >A comparison of interpretation by three different HIV type 1 genotypic drug resistance algorithms using sequences from non-clade B HIV type 1 strains.
【24h】

A comparison of interpretation by three different HIV type 1 genotypic drug resistance algorithms using sequences from non-clade B HIV type 1 strains.

机译:使用来自非进化B型HIV 1型菌株的序列对三种不同的HIV 1型基因型耐药性算法进行解释的比较。

获取原文
获取原文并翻译 | 示例
           

摘要

The advent of affordable ART has benefited HIV-infected individuals. Prospective studies have shown that the availability of drug resistance reports for infected individuals has allowed more effective regimens to be prescribed as compared to a control group whose physicians had no access to drug resistance reports. There is a paucity of information on the performance of genotypic algorithms on non-clade B HIV-1 strains, especially clade C. In this study the results obtained on submission of HIV-1 RT and PR sequences of non-clade B strains to the Stanford University HIV drug resistance database (SHDB) were compared to the results obtained from Geno2Pheno (G2P) and DR_Seqan (DS). For the study, we took samples from 93 treatment-naive individuals and 21 samples from 19 infected individuals showing detectable viral load while on ART. There were discrepancies in the clade identification results obtained from the SHDB and G2P databases. This feature was not available in DS. The mean observed concordance between SHDB and G2P was 85.6% while between SHDB and DC it was 37%. When the level of concordance was determined based on exposure to ART, the G2P was found to have a better level of concordance (76.8%) to SHDB as compared to SHDB versus DS (36%). We do not have phenotypic data for the strains included in this study and hence we are not in a position to assign a particular algorithm as being superior. These results also show a possible need for a subtype-specific algorithm for interpretation of HIV-1 genotypic drug resistance.
机译:负担得起的抗逆转录病毒疗法的出现使受艾滋病毒感染的人受益。前瞻性研究表明,与没有医生获得耐药报告的对照组相比,针对感染者的耐药报告的可获得性允许制定更有效的治疗方案。基因型算法在非进化B型HIV-1菌株,特别是进化枝C上的表现缺乏信息。在这项研究中,非进化B株的HIV-1 RT和PR序列提交给人类后获得的结果。将斯坦福大学的艾滋病毒抗药性数据库(SHDB)与从Geno2Pheno(G2P)和DR_Seqan(DS)获得的结果进行比较。对于这项研究,我们从93名未接受过治疗的个体中抽取了样本,并从19名受感染的个体中抽取了21份样本,这些样本在接受ART治疗时显示出可检测的病毒载量。从SHDB和G2P数据库获得的进化枝鉴定结果存在差异。 DS中没有此功能。 SHDB与G2P之间的平均观察到一致性为85.6%,而SHDB与DC之间的平均一致性为37%。当基于暴露于ART的情况确定一致性水平时,发现与SHDB对比DS(36%)相比,G2P与SHDB的一致性更好(76.8%)。我们没有该研究中所包含菌株的表型数据,因此我们无法将特定算法指定为优越算法。这些结果还表明可能需要用于解释HIV-1基因型耐药性的亚型特异性算法。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号